VALIDATION PLATFORM
FOR MICRORNA

Learn More
Contact Us

At Yenos Analytical, we’re leading the way in advanced disease detection with a unique validation platform for microRNA. MicroRNAs—tiny, non-coding RNA molecules that control gene expression—were discovered by Nobel Laureates Victor Ambros and Gary Ruvkun, who received the 2024 Nobel Prize in Physiology or Medicine for their groundbreaking work. Their groundbreaking work revealed how microRNA governs cellular functions, a discovery that opened new avenues for disease detection and treatment. Today, microRNA remains a vital tool in identifying early signs of cancer and other serious conditions.

The Power of Validating MicroRNA

Our specialized platform to validate microRNA sets us apart in the diagnostics field. Validating microRNA involves confirming its accuracy and relevance in detecting specific diseases, providing reliable results for our clients. With early detection as our priority, we ensure every test undergoes rigorous validation to maintain high standards of precision. Our technology analyzes urine samples to detect microRNA markers linked to 16 cancers and 11 other diseases at their onset, well before tumor formation, helping to save lives with timely intervention.

Choosing professionals to validate microRNA is crucial for accurate and trustworthy results. As the only company offering multi-cancer, multi-disease testing through a simple urine sample, Yenos Analytical is uniquely positioned to provide non-invasive, highly effective early disease detection. Our validation platform for microRNA reflects our commitment to accuracy, innovation, and convenience.

Trust Yenos Analytical to give you a head start in disease prevention. Contact us today to learn more about our validation platform for microRNA and the power of our early detection tests. Early detection saves lives—let us be your partner in wellness.

Please register and contact us if interested

1) To use our MinION enabled microRNA quantification services and solutions.

2) To participate remotely in a future IRB-approved study and provide your urine sample
for microRNA evaluation.
3) To collaborate in a grant application to implement and evaluate the Yenos microRNA
test in your facilities.
4) To use our consulting services in facilitating HPLC purity evaluation of your in-house
made mRNA batches.

Why is Early Detection Important?

A person holding two test tubes in their hands.

All men are at risk for prostate cancer. Out of every 100 American men, about 13 will get prostate cancer during their lifetime, and about 2 to 3 men will die from it.

A person in blue gloves holding a yellow object.

About 5-10% of pancreatic cancer patients survive past five years after diagnosis, and those with stage 4 pancreatic cancer have a five-year survival rate of 1%.

A woman in lab coat and gloves working on a device.

Screening mammograms miss about 1 in 8 breast cancers. After 10 yearly mammograms, the chance of having at least one false positive result is about 50%.

A person holding a test tube in their hands.
Multi-Cancer, Multi-Disease Screening

Yenos Analytical

  • Detecting any disease early reduces suffering and saves lives.
  • Other companies screen for tumor DNA in blood, but this is NOT EARLY because tumor DNA in blood exists only in the presence of tumors in the body.
  • The Yenos tests measure the levels of literature-known microRNA biomarkers in your sample and compare them to the ones from healthy or diseased/cancer patients.
  • Yenos tests can be equally well performed using blood or urine.
  • The Yenos urine tests are Direct-to-Consumer, and no doctor's prescription is required.
How It Works

Yenos Analytical

  • Complete online registration
  • Receive the Yenos kit via FedEx within two weeks
  • Mail back the kit with your urine sample by FedEx (shipping included)
  • Provide biannual updates on your health status for three years.
A purple and white rack with many cups of liquid.

TESTIMONIALS

My name is Xenia S. I live in Greece and was visiting California in May. I took the Yenos cancer urine test and was pleased to find out that I am cancer free.

A woman with glasses is smiling for the camera.

My name is Denny K., I am 47 years old and have 3 kids who are now taller than I. Sometimes I worry about breast cancer, so I took the Yenos cancer urine test and was happy to find out that I am cancer free.

A woman and girl smiling for the camera.

My name is Lisa F. and I am 54 years old. I recently became aware of a quick, easy and painless urine test I could take to screen for cancer. It is located in my hometown of El Dorado Hills, California at the Yenos Analytical lab. Within a matter of days, I was reassured that I am cancer free.

A woman smiling for the camera with a field in the background.

My name is Rick F. and I am 59 years old. While most men, like myself, are reluctant to visit a doctor or have lab tests done, I was at ease submitting a simple urine test to Yenos Analytical lab in El Dorado Hills. I was fortunate to quickly learn I didn’t have prostate cancer or any other cancers. What a relief!

A man with grey hair and wearing an orange shirt.

My name is Tessi K. and I am 71 years old. For the last 30 years, my doctor recommends that I do a mammogram and I did it twice and promised never to do it again. I took the Yenos cancer test, both blood and urine, and I come out free of cancer.

A woman with long hair and a black shirt

My name is Janette B. and I am 31 years old. I exercise, eat healthy and glad to know that there is a multi-cancer early detection test, the Yenos urine test, that includes people as young as I.

A woman is smiling for the camera in front of a city.